Clinical Trial Update: Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating moderators and biosignatures of antidepressant response for depression completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-12-26